|
The
21-gene assay and its impact on breast cancer treatment
Joseph Ragaz, MD, FRCPC
Cancer
Transitions: a supportive care program for cancer survivors
Challenges and successes
Amanda Ward, PhD; Richard Doll, MSW,
MSc; Svetlana Ristovski-Slijepcevic, PhD;
Arminee Kazanjian, DrSoc; Mitch Golant, PhD
Reports
from ASH and ASCO-GI
LYMPHOMA:
first-line treatment for advanced disease
Stephen Couban, MD, FRCPC
MULTIPLE MYELOMA: outcome improvements
using combination
regimens in older patients
Shamin Wadiwalla, MD; Tony Reiman,
MD, SM, FRCPC
COLON CANCER: impact of KRAS biomarker
in therapy selection
Ralph Wong, MD, FRCPC
COLON CANCER: recent advances in adjuvant
therapy
Timothy Asmis, MD, FRCPC
PANCREATIC CANCER: novel screening
tools
Sharlene Gill, MD, MPH, FACP,
FRCPC
PSYCHOSOCIAL CARE: evidence for end-of-life
planning
Ester Green RN, MSc(T); Bejoy Thomas,
MPhil, PhD
MEDICAL
MEETINGS ROSTER
DRUG & THERAPEUTIC UPDATES
|
